Advertisement

Topics

Cell Biosciences, Inc Company Profile

19:52 EDT 23rd June 2018 | BioPortfolio

Cell Biosciences is commercializing instrumentation and reagent systems to bring analytics to biology. In the “post-genomic” age, new tools are in high demand to enable researchers to rapidly develop assays for specific proteins in complex biological samples. High priority needs include specific detection of protein variants, detection of low abundance proteins in small sample volumes and improved quantification and throughput. Cell Biosciences is focused on these priorities to deliver new technology that will be enabling in these areas. We anticipate launch of our first instrument platform in 2006.

Location

1050 Page Mill Road
Palo Alto
California
94303
United States of America

Contact

Phone: 650) 859-1485
Fax: (650) 845-3540
Email: info@cellbiosciences.com


News Articles [1850 Associated News Articles listed on BioPortfolio]

ASC Biosciences, Inc. announces ad dates for first television commercial

About ASC Biosciences, Inc.ASC Biosciences, Inc. ("ASC" or the "Company") is a development stage biotechnology company with a proprietary adult stem cell platform capable Read more...

Greiner Bio-One Acquires 3D Cell Culture Technology Assets from Nano3D Biosciences, Inc.

Greiner Bio-One North America, Inc. has acquired 3D Cell Culture Technology previously owned by Nano 3D Biosciences, Inc. As an international distributor of these products since 2016, Greiner Bio-One ...

Greiner Bio-One acquires 3D Cell Culture Technology assets from Nano3D Biosciences

Greiner Bio-One North America, Inc. has acquired 3D Cell Culture Technology previously owned by Nano 3D Biosciences, Inc. As an international distributor of these products since 2016, Greiner Bio-One...

ACEA launches comprehensive and searchable online library of xCELLigence papers

In 2002 ACEA Biosciences pioneered real-time cellular impedance as a tool for dynamically tracking cell number, cell size, cell-substrate attachment strength, and cell invasion/migration.

Caladrius Biosciences () - Cell therapy platforms for unmet need

Edison Investment Research - Pharmaceutical & healthcare - Caladrius Biosciences: Caladrius is developing cell therapy (CT) products that extract, expand and bolster a patient’s own (autologous)...

Promethera Biosciences acquires Baliopharm

Belgian cell therapy company Promethera Biosciences has acquired Baliopharm, a Swiss biopharmaceutical…

Senti Biosciences Secures $53 Million Series A to Build the Future of Gene and Cell-Based Therapies

The post Senti Biosciences Secures $53 Million Series A to Build the Future of Gene and Cell-Based Therapies appeared first on SynBioBeta.

SOLID BIOSCIENCES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Solid Biosciences Inc. to Contact The Firm

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Solid Biosciences Inc. ("Solid Biosciences" or th...

Drugs and Medications [35 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

PubMed Articles [2678 Associated PubMed Articles listed on BioPortfolio]

Introduction.

Synthesis and biological evaluation of acyl derivatives of hydroxyflavones as potent antiproliferative agents against drug resistance cell lines.

The synthesis of hydroxyflavone derivatives is described. The acyl derivatives of 3-, 6-, 7-hydroxyflavones (compounds 2, 4, 6, respectively) and chrysin (5,7-dihydroxyflavone, 7) were obtained in hig...

Viable Cell Culture Banking for Biodiversity Characterization and Conservation.

Because living cells can be saved for indefinite periods, unprecedented opportunities for characterizing, cataloging, and conserving biological diversity have emerged as advanced cellular and genetic ...

Predicting cancer cell invasion by single-cell physical phenotyping.

The physical properties of cells are promising biomarkers for cancer diagnosis and prognosis. Here we determine the physical phenotypes that best distinguish human cancer cell lines, and their relatio...

Back cover.

Clinical Trials [5905 Associated Clinical Trials listed on BioPortfolio]

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM

The primary purpose of this study is to determine whether a tumor test recently developed by GenomeDx Biosciences known as Decipher® can predict aggressive prostate cancer with the same a...

Individual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic

The purpose of the expanded access program is to allow physicians to provide treatment with investigational drug, AB-PA01, for patients with serious or immediately life-threatening Pseudom...

Companies [1270 Associated Companies listed on BioPortfolio]

InQ Biosciences Corporation

InQ Biosciences is a provider of innovative technologies for cell growth and research. The company's InQ Cell Research System will empower scientists to unlock novel and more powerful approaches to ce...

InQ Biosciences

InQ Biosciences is a provider of innovative technologies for cell growth and research. The company’s InQ Cell Research System will empower scientists to unlock novel and more...

Cell Biosciences, Inc

Cell Biosciences is commercializing instrumentation and reagent systems to bring analytics to biology. In the “post-genomic” age, new tools are in high demand to enable researchers to rapidly deve...

Cellex Biosciences Incorporated

Cellex Biosciences is dedicated to providing cell processing products and services to meet the needs of human health care and biotechnology markets worldwide with stirred tank cell culturing systems, ...

JRH Biosciences

JRH Biosciences, a CSL Company, is a provider of sera, cell culture media and specialty reagents to the global health care industry.

More Information about "Cell Biosciences, Inc" on BioPortfolio

We have published hundreds of Cell Biosciences, Inc news stories on BioPortfolio along with dozens of Cell Biosciences, Inc Clinical Trials and PubMed Articles about Cell Biosciences, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cell Biosciences, Inc Companies in our database. You can also find out about relevant Cell Biosciences, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record